GlassScriptPhysician profile
Samuel Newell
NPI 1962495192
$9,887.71
in general payments reported to CMS, 2019-2025
40 companies · $863 in 2025
The $863 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $900 · 2020: $892 · 2021: $1,608 · 2022: $1,187 · 2023: $3,215 · 2024: $1,223 · 2025: $863.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,845 · Travel and Lodging: $1,456.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,845.16 |
| Travel and Lodging | $1,456.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,670.72 | 2019-2025 | |
| Livanova USA, INC. | $2,182.57 | 2019-2024 | Vns Therapy, Vns Therapy Sentiva Model 1000 Generator |
| Acorda Therapeutics, INC | $468.94 | 2019-2022 | |
| Pfizer INC. | $461.30 | 2019-2025 | |
| Teva Pharmaceuticals USA, INC. | $417.73 | 2019-2025 | Austedo Xr, Austedo Xr |
| Allergan, INC. | $351.58 | 2019-2022 | |
| Genzyme Corporation | $339.88 | 2019-2024 | |
| Sk Life Science, INC. | $297.88 | 2021-2025 | |
| Harmony Biosciences LLC | $283.44 | 2023-2025 | Wakix |
| Piramal Critical Care | $220.89 | 2020-2025 | |
| Biohaven Pharmaceuticals, INC. | $207.90 | 2021 | |
| Celgene Corporation | $182.98 | 2021-2024 | Zeposia |
| Amgen INC. | $176.89 | 2019-2025 | Uplizna |
| Medtronic USA, INC. | $152.95 | 2019-2020 | |
| Biogen, INC. | $124.99 | 2019-2024 | Vumerity, Skyclarys |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Newell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.